Maria Velez

6PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)English language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer.

|Sep 10, 2025
Identification of Targetable <i>EGFR</i> Mutations in Ovarian Cancer.

Arjan Gower, Susan Win, Rituparna Ganguly

|Jun 02, 2025
Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy.

Maria A Velez, Elliot S Kang, Chester A Thompson

|Aug 02, 2023
Consent document translation expense hinders inclusive clinical trial enrolment.

Maria A Velez, Beth A Glenn, Maria Garcia-Jimenez

|Dec 15, 2022
Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms?

Maria A Velez, Edward B Garon

|May 19, 2022
Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells.

Ashwin Somasundaram, Anthony R Cillo, Caleb Lampenfeld

Pageof 1

Frequent Collaborators

4 joint publications

Edward B Garon

3 joint publications

Aaron Lisberg

2 joint publications

Amy L Cummings

2 joint publications

Arjan Gower